Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

2seventy bio Q4 2024 GAAP EPS $(0.37) Misses $(0.24) Estimate, Sales $2.926 Miss $12.293M Estimate

Author: Benzinga Newsdesk | March 25, 2025 03:11pm
2seventy bio (NASDAQ:TSVT) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.24) by 54.17 percent. This is a 66.67 percent increase over losses of $(1.11) per share from the same period last year. The company reported quarterly sales of $2.926 which missed the analyst consensus estimate of $12.293 million by 100.00 percent. This is a 100.00 percent decrease over sales of $10.684 million the same period last year.

Posted In: TSVT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist